AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Anne Belli
Dec. 6--The former top scientist at Merck testified Monday that he initially concluded an internal study of Vioxx linked the drug to an increase in heart attacks and strokes less than a year after it was approved for sale.
In a videotaped deposition shown to a Houston jury, Dr. Edward Scolnick, the president of Merck Research Labs until 2002, acknowledged writing a company e-mail in which he noted that the cardiovascular links to Vioxx were "clearly there."
He said he changed his opinion just 18 days later after reviewing other data and literature, joining company officials in their position that there was no such link. Still, the cardiovascular issue continued to bother him even after Merck's marketing department put out a press release reaffirming the…